About Express Pharmaceuticals Private Limited
Data last updated:
Express Pharmaceuticals Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 17 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2019PTC137678. Its GSTIN is 36AAFCE7510F1ZV (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Nurali Barkatali Baghdiya and Aadil Anvarbhai Virani.
Its last annual general meeting (AGM) was held on 09 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #208 Varuna Towers Sri Vensai Projects Kompally, Secunderabad, Telangana, India – 500014.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.91 Cr, a decline of 29% compared to the previous year. For the same year it recorded a net profit of ₹17.06 Lakh (net margin 1.3%) and EBITDA of ₹16.1 Lakh (EBITDA margin 1.2%).
The company is associated with 1 brand: Express Pharmaceuticals.
For more details, the company can be reached via its website expresspharmaceuticals.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address#208 Varuna Towers Sri Vensai Projects Kompally, Secunderabad, Telangana, India – 500014
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Express Pharmaceuticals Private Limited
The main business activity of Express Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Express Pharmaceuticals Private Limited FY 2025 filings available
Express Pharmaceuticals Private Limited reported revenue of ₹12.91 Cr (down 29% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Express Pharmaceuticals Private Limited
Revenue fell 29% in the latest year. EBITDA fell 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Express Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹16.1 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹17.06 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Express Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Express Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Express Pharmaceuticals Private Limited
Express Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Meddoxx Pharmaceuticals Private Limited | ₹13.03 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Kozhikode, Kerala, India |
| Elinor Pharmaceuticals Private Limited | ₹12.99 Cr (FY 2024) | •••• | •••• | -30.0% | •••• | Hyderabad, Andhra Pradesh, India |
| Middle Mist Pharmaceuticals Private Limited | ₹12.96 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Chennai, Tamil Nadu, India |
| Medisonic Equipments Private Limited | ₹12.95 Cr (FY 2025) | •••• | •••• | 184.0% | •••• | Kalol, Gujarat, India |
| Optics India Equipments Private Limited | ₹12.94 Cr (FY 2023) | •••• | •••• | -26.0% | •••• | Anand, Gujarat, India |
| Express Pharmaceuticals Private Limited this company | ₹12.91 Cr (FY 2024) | •••• | •••• | -29.0% | •••• | Secunderabad, Telangana, India |
| Galen Pharmaceuticals Limited | ₹12.87 Cr (FY 2025) | •••• | •••• | -15.0% | •••• | Vadodara, Gujarat, India |
| Servo-Med Industries Private Limited | ₹12.83 Cr (FY 2025) | •••• | •••• | 59.0% | •••• | Mumbai, Maharashtra, India |
| Jayer India Pvt Ltd | ₹12.83 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | Kolkata, West Bengal, India |
| Relife Pharmaceuticals OPC Private Limited | ₹12.81 Cr (FY 2024) | •••• | •••• | 52.0% | •••• | Kolkata, West Bengal, India |
| Stech Ivf Solutions Private Limited | ₹12.8 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Express Pharmaceuticals by revenue in the Healthcare industry (Medical and Laboratory Equipment, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Express Pharmaceuticals Private Limited
Express Pharmaceuticals Private Limited is audited by RAMESH & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAMESH & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Express Pharmaceuticals Private Limited
Express Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nurali Barkatali Baghdiya | Director | 17 Dec 2019 | 6 Years 9 Months | Current |
| Aadil Anvarbhai Virani | Director | 17 Dec 2019 | 6 Years 9 Months | Current |
| Dilavar Alibhai Abhavani Also directs: Avenza Pharmaceuticals Private Limited | Director | 17 Dec 2019 | 6 Years 9 Months | Current |
Ownership and Shareholding of Express Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Express Pharmaceuticals Private Limited
Express Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Express Pharmaceuticals Private Limited
Express Pharmaceuticals operates one associated brand: Express Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and exporting in India. | expresspharmaceuticals.com |
Employees and EPFO Compliance at Express Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Express Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Express Pharmaceuticals Private Limited
Express Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Aadil Anvarbhai Virani was appointed as Director on 17 Dec 2019.
Credit Ratings, Litigation & Regulatory Alerts for Express Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Express Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Express Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Express Pharmaceuticals Private Limited
Express Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCE7510F1ZV | Telangana | Active | 21 Feb 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Express Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Express Pharmaceuticals Private Limited
Express Pharmaceuticals is an active private limited company based in Secunderabad, Telangana, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 17 December 2019 (7+ years old) and is registered under CIN U51909TG2019PTC137678.
Express Pharmaceuticals reported revenue of ₹12.91 Cr for FY 2024 (down 29% YoY).
Express Pharmaceuticals has 3 current directors:
- Nurali Barkatali Baghdiya - Director
- Aadil Anvarbhai Virani - Director
- Dilavar Alibhai Abhavani - Director
Express Pharmaceuticals reported a net profit of ₹17.06 Lakh (net margin 1.3%) and EBITDA of ₹16.1 Lakh (EBITDA margin 1.2%) for FY 2024, as per its filed financial statements.
The GSTIN of Express Pharmaceuticals is 36AAFCE7510F1ZV, registered in Telangana.
The CIN (Corporate Identification Number) of Express Pharmaceuticals is U51909TG2019PTC137678. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Express Pharmaceuticals was incorporated on 17 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Express Pharmaceuticals by revenue are Meddoxx Pharmaceuticals Private Limited, Elinor Pharmaceuticals Private Limited, Middle Mist Pharmaceuticals Private Limited, Medisonic Equipments Private Limited, Optics India Equipments Private Limited and 5 more, all in the Healthcare industry (Medical and Laboratory Equipment, Pharmaceuticals).
Aadil Anvarbhai Virani was appointed as Director on 17 Dec 2019. Dilavar Alibhai Abhavani was appointed as Director on 17 Dec 2019. Nurali Barkatali Baghdiya was appointed as Director on 17 Dec 2019.
Express Pharmaceuticals can be reached through the website expresspharmaceuticals.com. Its registered office is in Secunderabad, Telangana, India.
The registered office of Express Pharmaceuticals is at #208 Varuna Towers Sri Vensai Projects Kompally, Secunderabad, Telangana, India – 500014.